文献速递脑血管病外科

过去25年破裂动脉瘤治疗模式的转变:从开放手术到血管内治疗

Shifting Treatment Paradigms for Ruptured Aneurysms from Open Surgery to Endovascular Therapy Over 25 Years.
PubMed 文献 · World Neurosurg · 2017-07-20

该前瞻性机构数据库研究筛查1991至2016年动脉瘤性蛛网膜下腔出血(aSAH)患者,分析动脉瘤部位与治疗方式。共1306/1562例(83.6%)数据可用,开放手术占72.4%、血管内治疗占22.0%、5.7%未治疗;血管内治疗比例随5年间隔由3.0%升至41.9%,后循环动脉瘤增幅最大(由9.1%升至71.4%)。

要点

  • 血管内治疗比例随5年间隔由3.0%(1991-1996)升至41.9%(2012-2016)。
  • 后循环动脉瘤血管内治疗由9.1%升至71.4%,引领该趋势。
  • 大脑中动脉动脉瘤血管内治疗仍较少用(最初0%,现22.0%)。

核心结论

  • 过去25年本大型学术机构破裂颅内动脉瘤的血管内治疗稳步增加,与临床试验的积极数据、血管内技术进步和血管内专科医生经验增加相一致。

研究设计与样本

  • 前瞻性、经机构审查委员会批准的动脉瘤数据库,筛查1991至2016年aSAH患者,全程具备显微外科与血管内治疗能力,所有患者治疗前均行脑血管造影。

主要发现

  • 数据可用者为1306/1562例(83.6%),女性占72%,平均年龄52.8岁,平均动脉瘤大小8.0 mm。
  • 最常见载瘤血管为大脑前动脉(37.3%)、颈内动脉(33.3%)和大脑中动脉(14.6%),后循环动脉瘤占14.8%。
  • 开放手术治疗72.4%的动脉瘤,血管内治疗22.0%,5.7%未治疗。
  • 血管内治疗比例随5年间隔增加:3.0%(1991-1996)、13.4%(1997-2001)、17.2%(2002-2006)、24.3%(2007-2011)、41.9%(2012-2016)。
  • 后循环动脉瘤血管内治疗由9.1%升至71.4%;大脑前动脉与颈内动脉动脉瘤血管内治疗分别由2.9%和1.4%升至最近5年间隔的39.6%和40.7%;大脑中动脉动脉瘤血管内治疗最初为0%,现为22.0%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since the introduction of Gugliemi detachable coils in the early 1990s, major clinical studies have supported an increasing role for coil embolization of ruptured aneurysms. We assessed aneurysm location and treatment modality in aneurysmal subarachnoid hemorrhage (aSAH) over the past 25 years. METHODS: A prospective, institutional review board-approved aneurysm database was screened for patients presenting with aSAH from 1991 to 2016. Microsurgical and endovascular capabilities were present throughout. All patients underwent cerebral angiography prior to treatment. RESULTS: Data were available for 1306/1562 patients (83.6%) presenting with aSAH from 1991-2016. 72% were female, with average age 52.8 years, and average aneurysm size 8.0 mm. The most common vessel of origin was the anterior cerebral artery (37.3%), internal carotid artery (33.3%), and middle cerebral artery (14.6%). Posterior circulation accounted for 14.8% of the aneurysms. Open surgery was performed for 72.4% of aneurysms, endovascular treatment for 22.0%, and 5.7% were not treated. There was an increase in aneurysms treated by endovascular methods over 5-year intervals: 3.0% (1991-1996), 13.4% (1997-2001), 17.2% (2002-2006), 24.3% (2007-2011), and 41.9% (2012-2016). Posterior circulation aneurysms led this trend, increasing from 9.1% endovascular to 71.4%. Endovascular treatment increased from 2.9% and 1.4% of anterior cerebral artery and internal carotid artery aneurysms to 39.6% and 40.7%, respectively, in the most recent 5-year interval. By comparison, endovascular methods remained less commonly used for middle cerebral artery aneurysms (0% initially, now 22.0%). CONCLUSIONS: Endovascular treatment of ruptured intracranial aneurysms has steadily increased over the past 25 years at our major academic institution. This is consistent with positive data from clinical trials, advances in endovascular technology, and increasing experience of endovascular specialists.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bender MT, Wendt H, Monarch T, et al. Shifting Treatment Paradigms for Ruptured Aneurysms from Open Surgery to Endovascular Therapy Over 25 Years. World Neurosurg. 2017. PMID: 28736346. doi:10.1016/j.wneu.2017.07.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。